Shell Asset Management CO Boston Scientific Corp Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

A detailed history of Shell Asset Management CO transactions in Boston Scientific Corp stock. As of the latest transaction made, Shell Asset Management CO holds 17,494 shares of BSX stock, worth $1.56 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

17,494

Previous 6,544 167.33%

Holding current value

$1.56 Million

Previous $504,000 190.87%

% of portfolio

0.06%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$72.96 - $84.0 $798,911 - $919,800	10,950 Added 167.33%	17,494 $1.47 Million
Q1 2024 May 14, 2024	SELL	$57.6 - $68.62 $297,849 - $354,834	-5,171 Reduced 44.14%	6,544 $448,000
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $362,222 - $430,511	-7,447 Reduced 38.86%	11,715 $677,000
Q3 2023 Nov 08, 2023	SELL	$50.19 - $54.68 $23,037 - $25,098	-459 Reduced 2.34%	19,162 $1.01 Million
Q2 2023 Jul 28, 2023	SELL	$49.72 - $54.64 $122,261 - $134,359	-2,459 Reduced 11.14%	19,621 $1.06 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $6,583 - $7,304	-146 Reduced 0.66%	22,080 $1.11 Million
Q4 2022 Feb 07, 2023	SELL	$39.56 - $47.22 $204,723 - $244,363	-5,175 Reduced 18.89%	22,226 $1.03 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $247,976 - $740,753	-6,755 Reduced 19.78%	27,401 $1.06 Million
Q2 2022 Aug 09, 2022	BUY	$35.24 - $47.1 $16,703 - $22,325	474 Added 1.41%	34,156 $1.27 Million
Q1 2022 May 04, 2022	BUY	$40.9 - $45.1 $54,928 - $60,569	1,343 Added 4.15%	33,682 $1.49 Million
Q4 2021 Feb 09, 2022	BUY	$38.07 - $44.87 $232,988 - $274,604	6,120 Added 23.34%	32,339 $1.37 Million
Q3 2021 Nov 04, 2021	SELL	$41.23 - $45.88 $100,972 - $112,360	-2,449 Reduced 8.54%	26,219 $1.14 Million
Q2 2021 Aug 12, 2021	SELL	$38.58 - $44.24 $1.17 Million - $1.34 Million	-30,205 Reduced 51.31%	28,668 $1.23 Million
Q1 2021 May 10, 2021	BUY	$35.27 - $39.67 $46,909 - $52,761	1,330 Added 2.31%	58,873 $2.28 Million
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $152,722 - $193,355	4,607 Added 8.7%	57,543 $2.07 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $185,115 - $226,986	5,375 Added 11.3%	52,936 $2.02 Million
Q2 2020 Aug 10, 2020	SELL	$30.19 - $39.11 $1.17 Million - $1.52 Million	-38,915 Reduced 45.0%	47,561 $1.67 Million
Q1 2020 May 11, 2020	SELL	$25.83 - $45.71 $222,189 - $393,197	-8,602 Reduced 9.05%	86,476 $2.82 Million
Q4 2019 Feb 13, 2020	SELL	$37.87 - $45.37 $312,578 - $374,483	-8,254 Reduced 7.99%	95,078 $4.3 Million
Q3 2019 Nov 12, 2019	SELL	$40.31 - $43.45 $495,692 - $534,304	-12,297 Reduced 10.63%	103,332 $4.21 Million
Q2 2019 Aug 12, 2019	SELL	$34.91 - $42.98 $3.81 Million - $4.69 Million	-109,080 Reduced 48.54%	115,629 $4.97 Million
Q1 2019 May 09, 2019	BUY	$32.91 - $40.75 $3.41 Million - $4.22 Million	103,487 Added 85.37%	224,709 $8.62 Million
Q4 2018 Feb 13, 2019	SELL	$31.73 - $39.04 $1.36 Million - $1.67 Million	-42,801 Reduced 26.09%	121,222 $4.28 Million
Q3 2018 Nov 13, 2018	SELL	$32.83 - $38.63 $233,979 - $275,316	-7,127 Reduced 4.16%	164,023 $6.32 Million
Q2 2018 Aug 10, 2018	BUY	$26.84 - $34.32 $426,836 - $545,790	15,903 Added 10.24%	171,150 $5.6 Million
Q4 2017 Feb 09, 2018	BUY	$24.79 - $29.8 $332,681 - $399,916	13,420 Added 9.46%	155,247 $3.85 Million
Q3 2017 Oct 20, 2017	SELL	$26.26 - $29.17 $3.92 Million - $4.35 Million	-149,284 Reduced 51.28%	141,827 $4.14 Million
Q3 2017 Oct 18, 2017	BUY	$26.26 - $29.17 $7.64 Million - $8.49 Million	291,111	291,111 $3.44 Million

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $127B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Boston Scientific Corp Transaction History